Focus on Multiple Myeloma Part II


Focus on Multiple Myeloma Part II Banner



Date & Location
Friday, April 2, 2021, 12:00 AM - Saturday, April 2, 2022, 12:00 AM

Target Audience
Specialties - Hematology, Hematology and Oncology, Internal Medicine, Medical Genetics, Oncology, Pathology-Anatomic and Clinical, Pharmacy

Overview
Launch Date: 4/2/2021
Expiration Date: 4/2/2022

Registration
Focus on Multiple Myeloma Part II:
Please note, you will need to watch 2 videos under this module in order to receive credits:

5) Novel antibody-based therapy in Multiple Myeloma
6) The Promise of Combination Therapies with CAR T Cells in the Treatment of Multiple Myeloma

How to obtain continuing education credits after viewing the individual modules (1-2):

1) Sign in or create a new account by clicking "Sign In" in top left corner. *If you previously participated in a CME activity accredited by IU but do not know your password, please enter your email address and click on the 'Forget Your Password' button. Your password will be emailed to you.
2) Click on the "Tests" tile and select "Launch Website" to view the online videos.
3) After each module, click the Test tile to attest to completing the activity.
4) Click the MyCME button and click the Evaluations and Certificates tile. 
5) Choose the Type of Credit, complete the CME Evaluation, and click Submit.
6) On the Evaluations and Certificates page, click Download Certificate.

Accreditation
In support of improving patient care, Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Nurses
Indiana University School of Medicine designates this activity for a maximum of 1.5 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
Indiana University School of Medicine designates this activity for (ACPE UAN JA4008178-0000-21-073-H01-P;
JA4008178-0000-21-073-H01-T) 1.5 ACPE contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Physicians
Indiana University School of Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

References:

Kumar S. COMY 2019 May 16. Oral presentation.

Mateos M.V. et al. J Clin Onc. 2019 Jun 02.

Lakshman A. et al. Blood Cancer J. 2018 Jun 12. DOI: 10.1038/s41408-018-0077-4

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma
María-Victoria Mateos, Miguel-Teodoro Hernández, Pilar Giraldo, Javier de la Rubia, Felipe de Arriba, Lucía López Corral, Laura Rosiñol, Bruno Paiva, Luis Palomera, Joan Bargay, Albert Oriol, Felipe Prosper, Javier López, Eduardo Olavarría, Nuria Quintana, José-Luis García, Joan Bladé, Juan-José Lahuerta, Jesús-F San Miguel

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial , Susanna Jacobus, Rafael Fonseca, Matthias Weiss, Shaji Kumar, Robert Z Orlowski, Jonathan L Kaufman, Abdulraheem M Yacoub, Francis K Buadi, Timothy O'Brien, Jeffrey V Matous, Daniel M Anderson, Robert V Emmons, Anuj Mahindra, Lynne I Wagner, Madhav V Dhodapkar, S Vincent Rajkumar

Gandhi Leukemia 2019; Chari NEJM 2019; Lonial Lancet Oncol 2020; Richardson EHA 2020; Van De Donk ASH 2020; Kumar ASH 2020; Garfall ASH 2020; Chari ASH 2020; Cohen ASH 2020; Rodriguez ASH 2020; Ocio ASH 2020; Harrison ASH 2020; Madduri ASH 2020

Hengeveld et al Bl Cancer J 2015  ; Maus, June, Clin Can Res 2013

Trudel, et al. Blood Cancer J 2019; Lonial, et al. Lancet Oncol 2019; Nooka, et al. Hematology Reports 2020;; Popat, et al. ASH 2020; Kumar, et al. ASH 2020

Topp, et al. Journal of Clinical Oncology 2020; Harrison, et al. ASH 2020; Costa, et al. ASH 2019; Lesokhin, et al. ASH2020; Madduri, et al. ASH 2020; Garfall, et al. ASH 2020; Rodriguez, et al. ASH 2020

Mateos MV et al. Current hematologic malignancy reports. 2013; 8(4): 270-6.

Termini et al. ASH 2020: abstract 57

Mateos MV, et al. NEJM 2013; 369:438-47

Ghobrial I, et al. ASH 2018: abstract 154

Bustoros M et al. ASH 2019: abstract 804

Landgren O et al. JAMA 2017

Additional Information

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.


Credits
AMA PRA Category 1 Credits™ (1.50 hours), ACPE Contact Hours (1.50 hours), ANCC Contact Hours (1.50 hours), Non-Physician Attendance (1.50 hours)